Filtered By:
Cancer: Lung Cancer
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 15396 results found since Jan 2013.
Correction: Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
by The PLOS Medicine Staff
Source: PLoS Medicine - January 28, 2015 Category: Internal Medicine Authors: The PLOS Medicine Staff Source Type: research
Is traditional Chinese herbal medicine effective in prolonging survival times in extensive-stage small-cell lung cancer patients?
Publication date: Available online 3 October 2015 Source:Integrative Medicine Research Author(s): Jungtae Leem
Source: Integrative Medicine Research - October 4, 2015 Category: Complementary Medicine Source Type: research
Chinese Herbal Medicine for Improving Quality of Life Among Nonsmall Cell Lung Cancer Patients: Overview of Systematic Reviews and Network Meta-Analysis
Abstract: For patients with nonsmall cell lung cancer (NSCLC) receiving chemotherapy, current clinical evidence has indicated add-on benefit of Chinese herbal medicine (CHM) in improving quality of life (QoL). However, the relative performance among different CHM is unknown.
The aim of this overview of systematic reviews (SRs) and network meta-analyses (NMA) is to evaluate the comparative effectiveness of different CHM.
Seven electronic databases including both international databases and Chinese databases were searched.
SRs focus on randomized controlled trials (RCTs) with comparison of CHM plus chemotherapy against ch...
Source: Medicine - January 1, 2016 Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Preface.
Authors: Ahmad A, Gadgeel SM
PMID: 27119128 [PubMed - in process]
Source: Advances in Experimental Medicine and Biology - April 28, 2016 Category: Research Tags: Adv Exp Med Biol Source Type: research
Managing comorbidities in idiopathic pulmonary fibrosis
Blair G Fulton,1 Christopher J Ryerson1,2 1Department of Medicine, 2Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada Abstract: Major risk factors for idiopathic pulmonary fibrosis (IPF) include older age and a history of smoking, which predispose to several pulmonary and extra-pulmonary diseases. IPF can be associated with additional comorbidities through other mechanisms as either a cause or a consequence of these diseases. We review the literature regarding the management of common pulmonary and extra-pulmonary comorbidities, including chronic obstructive pulmonary disease, lung can...
Source: International Journal of General Medicine - September 21, 2015 Category: Journals (General) Tags: International Journal of General Medicine Source Type: research
Precision Nuclear Medicine Enabled by Ultra-High Definition PET: Improved Lesion Detectability Using Digital PET Technology in Patients with Malignant/metastatic Lung Lesions
Conclusions 18F-FDG PET imaging of malignant/metastatic pulmonary disease burden is essential for accurate oncologic staging and patient management. While there are already obvious advantages using standard definition reconstruction in dPET imaging compared to cPET, our findings demonstrate an exciting clinical potential of routine high- and ultra-high definition dPET imaging to markedly improve lesion detectability in a variety of pulmonary lesions (especially for lesions ≤ 15mm). The observed capabilities of the digital photon counting PET technology will likely drive new paradigm-shifting precision nuclear med...
Source: Journal of Nuclear Medicine - May 23, 2016 Category: Nuclear Medicine Authors: Knopp, M., Wright, C., Binzel, K., Zhang, J., Saif, T., Siva, A., Shields, P., Tung, C.-h., Maniawski, P. Tags: Lung Cancer III Source Type: research
Non-invasive imaging of the biological behavior of mast cells in living mice with lung cancer using a combined optical and nuclear medicine imaging
Conclusions Herein, we successfully monitored the migration of mast cells to tumor lesion with effluc gene and the enhanced glucose uptake in lung tumor by migrated mast cells with F-18 FDG PET/CT. These results suggest that molecular imaging approach with optical and nuclear medicine imaging is a valuable tool to better understand the biological role of mast cells in tumor microenvironment.
Source: Journal of Nuclear Medicine - May 23, 2016 Category: Nuclear Medicine Authors: Oh, S.-G., ho won, L., Debraj Singh, T., Lee, S. B., Ahn, S., Yoon, S., Lee, S.-W., Jeong, S. Y., Ahn, B.-C., Lee, J., Jeon, Y. H. Tags: MTA I: Basic Science Posters Source Type: research
Society of Behavioral Medicine supports implementation of high quality lung cancer screening in high-risk populations
AbstractThe Society of Behavioral Medicine (SBM) supports the United States Preventive Services Task Force (USPSTF) recommendation of low-dose computed tomography (LDCT) screening of the chest for eligible populations to reduce lung cancer mortality. Consistent with efforts to translate research findings into real-world settings, SBM encourages health-care providers and health-care systems to (1) integrate evidence-based tobacco treatment as an essential component of LDCT-based lung cancer screening, (2) examine the structural barriers that may impact screening uptake, and (3) incorporate shared decision-making as a clinic...
Source: Translational Behavioral Medicine - September 18, 2016 Category: Global & Universal Source Type: research
Sample types applied for molecular diagnosis of therapeutic management of advanced non-small cell lung cancer in the precision medicine
Journal Name: Clinical Chemistry and Laboratory Medicine (CCLM) Issue: Ahead of print
Source: Clinical Chemistry and Laboratory Medicine - May 17, 2017 Category: Laboratory Medicine Source Type: research
In vivo visualization of the migration of mast cell toward lung cancer lesion using nuclear medicine imaging with sodium iodide symporter
Conclusion: We successfully visualized the migration of reporter mast cells to tumor lesion in living mice of lung cancer with NIS reporter gene, suggesting that nuclear medicine imaging approach with NIS gene is a feasible tool to better understand biological role of mast cells in cancer microenvironment. Research Support: Figure 1. I-124 PET/CT imaging of migrated mast cells to tumor lesion with sodium iodide symporter. Yellow circle indicate LLC tumors.
Source: Journal of Nuclear Medicine - May 24, 2017 Category: Nuclear Medicine Authors: Oh, S.-G., Lee, S. B., Ji, H. D., Lee, J.-E., Singh, T. D., Kim, S. K., Jeong, S. Y., Ahn, B.-C., Lee, J., Lee, S.-W., Jeon, Y. H. Tags: Radiochemistry: Imaging of Cancer Source Type: research
Personalized medicine for non-small cell lung cancer: where are we now and where can we go?
Authors: Ezeife DA, Leighl NB
PMID: 29187004 [PubMed - as supplied by publisher]
Source: Expert Review of Respiratory Medicine - December 2, 2017 Category: Respiratory Medicine Tags: Expert Rev Respir Med Source Type: research
Future Medicine's Oncology Management series of journals to be fully Open Access from 2018
(Future Science Group) Future Medicine is pleased to announce that, from January 2018, the eight journals within its Oncology Management Series -- Breast Cancer Management, CNS Oncology, Colorectal Cancer, Hepatic Oncology, International Journal of Endocrine Oncology, International Journal of Hematologic Oncology, Lung Cancer Management and Melanoma Management, will be following a fully open access model.
Source: EurekAlert! - Medicine and Health - January 26, 2018 Category: International Medicine & Public Health Source Type: news
Revolution in Respiratory Medicine
The diagram in Fig. 1 summarizes the growth of interventional pulmonology (IP) and its overlap with different medical and surgical subspecialties. IP tools and techniques have revolutionized many aspects of medicine, including the diagnosis and staging of lung cancer, the management of chronic malignant and nonmalign ant pleural effusions, the approach to complicated airway obstruction by benign and malignant diseases, and the management of chronic and recurrent diseases such as tracheal stenosis and tracheobronchomalacia.
Source: Clinics in Chest Medicine - February 10, 2018 Category: Respiratory Medicine Authors: Ali I. Musani Tags: Preface Source Type: research
The Liquid Biopsy, What is it, How is it Provided, and What is the Role of the Pulmonologist
Non–small cell lung carcinoma represents the most common form of lung cancer, which itself is the cancer responsible for most deaths annually worldwide. In the advances toward personalized medicine in cancer care, the liquid biopsy is the most recent leap forward allowing treatment based upon driver mutations harbored within a patient. Cell free DNA (cfDNA) is shed from cells within the body, and the tumor cells are no different. This circulating tumor DNA can be sampled and tested for therapeutic and diagnostically actionable genes and gene mutations. Because of the relatively uncommon nature of these circulating tumor ...
Source: Clinical Pulmonary Medicine - March 1, 2018 Category: Respiratory Medicine Tags: Topics in Pulmonary Medicine Source Type: research
Complementary and Integrative Medicine in Lung Cancer: Questions and Challenges
The Journal of Alternative and Complementary Medicine,Volume 24, Issue 9-10, Page 862-871, September/October 2018.
Source: The Journal of Alternative and Complementary Medicine - September 24, 2018 Category: Complementary Medicine Authors: Moshe Frenkel Robert Slater Kenneth Sapire Victor Sierpina Source Type: research
